dantrolene sodium (Par Pharmaceutical Inc.)


Welcome to the PulseAid listing for the dantrolene sodium drug offered from Par Pharmaceutical Inc.. This Decreased Striated Muscle Contraction [PE],Decreased Striated Muscle Tone [PE],Skeletal Muscle Relaxant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Par Pharmaceutical Inc.
NON-PROPRIETARY NAME: dantrolene sodium
SUBSTANCE NAME: DANTROLENE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Striated Muscle Contraction [PE],Decreased Striated Muscle Tone [PE],Skeletal Muscle Relaxant [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2016-02-19
END MARKETING DATE: 0000-00-00


dantrolene sodium HUMAN PRESCRIPTION DRUG Details:

Item Descriptiondantrolene sodium from Par Pharmaceutical Inc.
LABELER NAME: Par Pharmaceutical Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 25(mg/1)
START MARKETING DATE: 2016-02-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49884-362_22b3ba15-71c7-4881-a95b-00070d05487b
PRODUCT NDC: 49884-362
APPLICATION NUMBER: NDA017443

Other DANTROLENE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingDantrolene Sodium
Avera McKennan HospitalDantrolene Sodium
Cardinal HealthDantrolene Sodium
Carilion Materials ManagementDantrolene Sodium
Eagle Pharmaceuticals, Inc.RYANODEX
Impax GenericsDantrolene Sodium
Par Pharmaceutical Inc.dantrolene sodium
Par Pharmaceutical, Inc.Dantrium
US WorldMeds, LLCRevonto